Podcasts about life sciences

Links For The Occult Rejectshttps://linktr.ee/theoccultrejectsOccult Research Institutehttps://www.occultresearchinstitute.org/Substackhttps://substack.com/@theoccultrejects?r=7auau0&utm_campaign=profile&utm_medium=profile-pageCash Apphttps://cash.app/$theoccultrejectsVenmo@TheOccultRejectsBuy Me A Coffeebuymeacoffee.com/TheOccultRejectsPatreonhttps://www.patreon.com/TheOccultRejectsGreek and Roman Primary SourcesAristotle. Generation of Animals. Translated by A. L. Peck. Loeb Classical Library 366. Cambridge, MA: Harvard University Press, 1942.Galen. On Semen. Edited and translated by Phillip De Lacy. Corpus Medicorum Graecorum V 3, 1–2. Berlin: Akademie-Verlag, 1992.Galen. On the Usefulness of the Parts of the Body. Translated by Margaret Tallmadge May. 2 vols. Ithaca, NY: Cornell University Press, 1968.Hippocrates. Generation, Nature of the Child, Diseases IV. Translated by Paul Potter. Loeb Classical Library 520. Cambridge, MA: Harvard University Press, 2012.Hippocrates. On the Seed and the Nature of the Child. In Hippocratic Writings, edited by G. E. R. Lloyd and translated by J. Chadwick and W. N. Mann. London: Penguin, 1978.Soranus. Soranus' Gynecology. Translated by Owsei Temkin. Baltimore: Johns Hopkins University Press, 1956.Greek and Roman Medicine, Gender, and SexualityConnell, Sophia M. Aristotle on Female Animals: A Study of the Generation of Animals. Cambridge: Cambridge University Press, 2016.Dean-Jones, Lesley. Women's Bodies in Classical Greek Science. Oxford: Clarendon Press, 1994.Flemming, Rebecca. Medicine and the Making of Roman Women: Gender, Nature, and Authority from Celsus to Galen. Oxford: Oxford University Press, 2000.King, Helen. Hippocrates' Woman: Reading the Female Body in Ancient Greece. London: Routledge, 1998.Laqueur, Thomas. Making Sex: Body and Gender from the Greeks to Freud. Cambridge, MA: Harvard University Press, 1990.Lloyd, G. E. R. Science, Folklore and Ideology: Studies in the Life Sciences in Ancient Greece. Cambridge: Cambridge University Press, 1983.Mattern, Susan P. The Prince of Medicine: Galen in the Roman Empire. Oxford: Oxford University Press, 2013.Nutton, Vivian. Ancient Medicine. 2nd ed. London: Routledge, 2013.Ayurveda, Kāma, and South Asian Sexual TraditionsDoniger, Wendy, and Sudhir Kakar, trans. Kamasutra. Oxford: Oxford University Press, 2002.Flood, Gavin. The Tantric Body: The Secret Tradition of Hindu Religion. London: I. B. Tauris, 2006.Meulenbeld, G. Jan. A History of Indian Medical Literature. 5 vols. Groningen: Egbert Forsten, 1999–2002.Sanderson, Alexis. “The Śaiva Age: The Rise and Dominance of Śaivism during the Early Medieval Period.” In Genesis and Development of Tantrism, edited by Shingo Einoo, 41–350. Tokyo: Institute of Oriental Culture, University of Tokyo, 2009.White, David Gordon. Kiss of the Yoginī: “Tantric Sex” in Its South Asian Contexts. Chicago: University of Chicago Press, 2003.White, David Gordon. The Alchemical Body: Siddha Traditions in Medieval India. Chicago: University of Chicago Press, 1996.Wujastyk, Dominik. The Roots of Ayurveda: Selections from Sanskrit Medical Writings. 3rd ed. London: Penguin, 2003.Chinese Medicine and Daoist CultivationDespeux, Catherine. Taoism and Self Knowledge: The Chart for the Cultivation of Perfection. Leiden: Brill, 2018.Furth, Charlotte. A Flourishing Yin: Gender in China's Medical History, 960–1665. Berkeley: University of California Press, 1999.Kohn, Livia. Daoist Body Cultivation: Traditional Models and Contemporary Practices. Magdalena, NM: Three Pines Press, 2006.Lo, Vivienne. “The Influence of Nurturing Life Culture on the Development of Western Han Acumoxa Therapy.” In Innovation in Chinese Medicine, edited by Elisabeth Hsu, 19–50. Cambridge: Cambridge University Press, 2001.Pregadio, Fabrizio, ed. The Encyclopedia of Taoism. 2 vols. London: Routledge, 2008.Schipper, Kristofer. The Taoist Body. Translated by Karen C. Duval. Berkeley: University of California Press, 1993.Wile, Douglas. Art of the Bedchamber: The Chinese Sexual Yoga Classics Including Women's Solo Meditation Texts. Albany: State University of New York Press, 1992.Comparative and Methodological StudiesFoucault, Michel. The History of Sexuality. Vol. 2, The Use of Pleasure. Translated by Robert Hurley. New York: Vintage Books, 1990.Hopwood, Nick, Rebecca Flemming, and Lauren Kassell, eds. Reproduction: Antiquity to the Present Day. Cambridge: Cambridge University Press, 2018.Wiesner-Hanks, Merry E., and Mathew Kuefler, eds. The Cambridge World History of Sexualities. Vol. 2, Systems of Thought and Belief. Cambridge: Cambridge University Press, 2024.Also want to remind people about the website, if you're into reading we have tons of information by multiple contributors, and we got t-shirts up on the site if you're interested. Fun fact, the art is all based on the eyeball. 

Jim Toman is an MES Consultant at Grantek. Jim has been helping manufacturers with their software, engineering and MES processes for over 30 years. Currently Jim offers advising and consulting services for Manufacturing Execution Systems (MES) applications and capabilities. Jim's role brings together decades of experience in MES systems specification, development, implementation, integration, productization, standards, continuous improvement, and quality. The Industry 4.0 Podcast with Grantek delivers a look into the world of manufacturing, with a focus on stories and trends that lead to better solutions.   Our guests will share tips and outcomes that will help improve your productivity. You will hear from leading providers of Industrial Control System hardware and software, Grantek experts and leaders at best-in-class industry associations that serve the Data Centers, Life Sciences, CPG and Food & Beverage industries.

Biofilms are everywhere: your teeth, your kitchen sponge, and even medical implants. Scientists are uncovering how these highly organized microbial communities protect bacteria from antibiotics and the immune system, and how understanding their hidden lives could help us fight some of the scariest infections, particularly those that disproportionately impact people with cystic fibrosis.Learn more about CALM here.Check out Wow If True wherever you listen to podcasts!A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

*This episode of the pharmaphorum podcast is brought to you in association with Klick Health* Europe continues to offer major life sciences advantages: deep scientific talent, strong clinical expertise, mature research infrastructure, and significant manufacturing capability. Indeed, biotech companies continue to invest in Europe as a long-term hub for scientific innovation, clinical research, and economic growth. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Giancarlo Benelli, SVP & Head of Europe at BeOne Medicines, for a conversation on what Europe must do, however, in order to remain globally competitive. Benelli discusses EFPIA's latest reports on Europe's competitiveness as a location for the life sciences industry, as well as exploring why it is at the same time losing ground to the US and to China. Additionally, Benelli comments on the importance of regulatory stability looking forward. You can listen to episode 275 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from. *This episode of the pharmaphorum podcast is brought to you in association with Klick Health*

Sarah Russell picked up a phrase at her new job at Anthropic: a "non-regrettable primitive." It's how she describes the kind of infrastructure she thinks Anthropic should be building in healthcare, and it says a lot about how one of the most closely watched companies in health AI is positioning itself. In this episode, Steve talks with Sarah Russell, MD healthcare and life sciences lead at Anthropic. This conversation comes as Anthropic heads toward what's shaping up to be one of the most anticipated IPOs in years.We cover:What Anthropic is doing in healthcareWhy HIPAA is struggling to keep up with AI agents Where she thinks AI will change care first (it's not where you'd expect!)The two very different bars regulators are weighing AI against, and why the choice matters more than most people realizeThe one piece of advice from her father that still shapes how she builds teams, and what she tells doctors nervous about a career in medicine nowAbout our guest:Sarah currently works on healthcare and life sciences projects at Anthropic. She is particularly passionate about research that explores how to make Claude safer and less confidently wrong. Prior to Anthropic, she was at Google X, an innovation hub at Alphabet, where she learned to lead teams of smart engineers building ML- and LLM-based products. Seeing the earliest version of Google's Med-PaLM summarize a patient chart made her excited about healthcare technology all over again. Prior to Google, she was a CMIO in the VA system and a start-up founder. A graduate of Harvard College and Harvard Medical School, Sarah did her internal medicine residency at MGH and completed an MBA at Wharton. She still practices part-time in Urgent Care at Stanford, where she is an Assistant Professor.⸺

Samantha and Margaret chat with Dr. Anne Thomas, a recently hired biology professor in BYU's College of Life Sciences, and undergraduate student Madi Van Valkenburg about their research interests and field experiences. Together, they discuss the questions driving their work, what the research process looks like, and how hands-on mentorship helps students gain experience as scientists.This episode was recorded on March 5, 2026.

In this Industry Insight episode of the On Aon podcast, Steve Schell and Nancy McCarrick discuss why healthcare strategy has become a critical business priority for life sciences organizations. As healthcare costs continue to rise, leaders must make disciplined decisions that protect workforce health, support innovation and strengthen long-term growth.Schell and McCarrick explore why healthcare benefit decisions can no longer sit solely within HR, how data-driven insights can help leaders allocate resources more effectively and why closer alignment across finance, HR and the business is essential to building sustainable workforce strategies. They also examine how AI, advanced analytics and targeted investments can help organizations make smarter healthcare decisions, unlock greater value from benefits programs and position themselves to stay ahead in the competition for highly skilled talent.Key Takeaways:            Healthcare strategy is now a business issue, influencing talent outcomes, workforce performance and an organization's ability to deliver on growth objectives.Leading organizations are using data and benchmarking insights to identify where investments create the greatest value. Organizations that align finance, HR and business leaders around a long-term strategy are better-positioned to manage costs, strengthen workforce health and stay ahead of future challenges.Experts in this episode:          Steve Schell, Global Life Sciences Leader, AonNancy McCarrick, Senior Vice President, Health Solutions, AonKey Moments:            (01:40) Why healthcare costs are becoming a strategic leadership issue and what makes workforce and benefits decisions particularly consequential in the life sciences industry.(05:50) How leading organizations are using data, benchmarking and total rewards insights to align healthcare investments with talent and business priorities.(09:45) How AI, advanced analytics and targeted healthcare investments are helping organizations create more informed, future-focused workforce strategies.Soundbites:            Steve Schell:“Poor benefit decisions do not stay in the benefit budget. They show up in talent, productivity and growth. Across-the-board cuts can damage the employer proposition precisely where the life sciences industry needs hard-to-find talent.”Nancy McCarrick: “The central message is that healthcare strategy can no longer be separated from talent strategy. Organizations that succeed won't rely on one-time cost cuts. They're going to use data to understand workforce, evaluate healthcare within the total rewards pie and build that multi-year roadmap.”

In this episode of Tiny Show and Tell Us, we explore the fascinating history of embalming, from ancient mummies to arsenic-laced funeral practices (that weren't all that long ago!). Then we chat about cadaver dissection, the importance of Leonardo da Vinci's anatomical drawings, and whether virtual reality could someday replace anatomy labs. Plus, what's the real story behind those creepy iron cages found above burial plots in old cemeteries?Learn more about CALM here.We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org or fill out this form with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

BUFFALO, NY — September 9, 2026 — A new #research paper was #published in Volume 18 of Aging on August 13, 2026, titled “Protective effects of three herbal extracts on mitochondrial dysfunction in VPS13C-knockdown SH-SY5Y cells: implications for Parkinson's disease.” The study was led by co-first authors Yih-Ru Wu and Chih-Hsin Lin from the Chang Gung Memorial Hospital, Chang Gung University College of Medicine in Taoyuan, Taiwan, and Pei-Syuan Huang from the School of Life Science at National Taiwan Normal University in Taipei, Taiwan. Corresponding authors I-Cheng Chen and Guey-Jen Lee-Chen are from the School of Life Science at National Taiwan Normal University. The paper identifies Wu, Lin, and Huang as equal contributors. Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized primarily by dysfunction and loss of dopaminergic neurons in the substantia nigra. Although its causes are complex, mitochondrial dysfunction and oxidative stress are important biological processes implicated in both sporadic and inherited forms of the disease. The researchers focused on VPS13C, also known as PARK23, a gene associated with a rare autosomal recessive form of early-onset parkinsonism. Loss of VPS13C function has previously been linked to impaired mitochondrial function. The study investigated three extracts used in traditional Chinese medicine: Uncaria rhynchophylla (UR), Gardenia jasminoides (GJ), and Scutellaria baicalensis (SB). Previous experimental studies have reported neuroprotective effects from these plants or their bioactive constituents in models relevant to PD. The researchers examined whether the extracts could protect cells against mitochondrial dysfunction associated with reduced VPS13C expression. Chemical analyses identified several potentially bioactive constituents in the extracts. UR contained rhynchophylline and isorhynchophylline; GJ contained geniposide and crocin; and SB contained several flavonoids, including baicalin, wogonoside, baicalein, wogonin, and oroxylin A. Across the concentrations initially tested, the three extracts maintained greater than 90% viability in SH-SY5Y cells after 24 hours, indicating low cytotoxicity under these experimental conditions. Full press release - https://www.aging-us.com/news-room/three-herbal-extracts-protect-mitochondrial-function-in-a-cellular-model-of-parkinsons-disease DOI - https://doi.org/10.18632/aging.206409 Corresponding authors - I-Cheng Chen - ichen@ntnu.edu.tw, Guey-Jen Lee-Chen - t43019@ntnu.edu.tw Abstract video - https://www.youtube.com/watch?v=kM8hO89d_9k Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206409 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, Parkinson's disease, traditional Chinese medicine, VPS13C knockdown, mitochondrial dysfunction, oxidative stress To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

Jeremy Heffner, MD, FACS is a board-certified trauma surgeon, former Chair of Surgery at Lima Memorial Health System, and cofounder of Surgery Unified, one of the largest physician-led communities in surgery. His perspective carries weight because he has spent decades inside operating rooms, hospital leadership, physician culture, and the growing collision between medicine and corporate healthcare. He grew up in a blue-collar Ohio family of firefighters, railroad workers, police officers, and tradespeople. Medicine represented something rare: a career that combined service, stability, and purpose. He pursued engineering, earned his medical degree, completed trauma surgery fellowship training at the University of Michigan, and entered a profession that taught physicians to sacrifice themselves for patients.Then the rules changed.This conversation traces the gap between the medicine physicians were trained to practice and the healthcare industry that emerged around them. Administrative burden expanded. Insurance companies gained influence over treatment decisions. Prior authorization became routine. Hospital systems consolidated. Physicians retained responsibility for outcomes while losing authority over the conditions required to achieve them.Heffner describes watching colleagues struggle with burnout, moral injury, PTSD, and growing frustration with a system that increasingly inserts business incentives between clinicians and patients. He explains why younger physicians are entering medicine with a level of visibility that previous generations never had. They see the paperwork, the denials, the loss of autonomy, and the personal cost before they ever finish training.The discussion moves beyond physician dissatisfaction and into the broader consequences for patients. When insurers delay care, hospitals absorb costs, clinicians absorb stress, and patients absorb uncertainty. The financial incentives remain intact while trust erodes across every level of the healthcare system.At its core, this episode examines what happens when a profession built around service finds itself operating inside an industry built around extraction. The result affects physicians, nurses, caregivers, and every patient forced to navigate the consequences.RELATED LINKSJeremy Heffner⁠Surgery Unified⁠SurgeOn⁠University of Michigan Department of Surgery⁠KevinMD⁠Suck It Up Buttercup⁠FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of HFS Unfiltered, Rohan Kulkarni, Executive Research Leader for Healthcare and Life Sciences at HFS Research, joins Titus Leo, SVP of Sagility Provider Solutions, to discuss the HFS Horizons HCP Provider Services 2026 study and explore how healthcare providers can respond to growing financial pressure, rising costs, and changing reimbursement models.What you'll hear:Why traditional healthcare operating and reimbursement models are becoming unsustainable Three bold ideas: direct-to-employer capitation, smarter self-pay strategies, and AI-enabled proactive care Why healthcare services are shifting from FTE-based to outcome-based models How clinical RCM, agentic AI, and patient engagement can improve financial and operational performance How Sagility is advancing these capabilities through Synchrony, AI/GenAI, and Birch AIKey takeaways:Providers need new revenue and care models to build resilience amid continued margin pressure. AI can move healthcare from reactive treatment toward proactive disease prevention and management. Outcome-based partnerships will increasingly require service providers to deliver measurable business and clinical impact. The convergence of services-as-software, RCM, and agentic AI is creating new opportunities to transform healthcare operations.Learn more about the associated reports here: HFS Horizons: HCP Service Providers, 2026 - https://www.hfsresearch.com/research/hfs-horizons-hcp-service-providers-2026/Point of View: Financial duress will be the forcing function for purposeful AI in US healthcare - https://www.hfsresearch.com/research/financial-duress-us-healthcare/Point of View: The patient is the new payer, and self-pay must anchor the provider's survival - https://www.hfsresearch.com/research/patient-payer-self-pay-survival/#Healthcare #RevenueCycle #RCM #ValueBasedCare #HealthcareAI #AgenticAI #PatientEngagement #Sagility #HFSResearch #HealthcareProviders

In this episode, Professor Emeritus at Cornell University College of Agricultural and Life Sciences breaks down what happens in a symbiotic relationship between trichoderma species and plant species.   Subscribe for more content on sustainable farming, market farming tips, and business insights!   Get market farming tools, seeds, and supplies at Modern Grower. Follow Modern Grower:  Instagram  Instagram Listen to other podcasts on the Modern Grower Podcast Network:  Carrot Cashflow  Farm Small Farm Smart  Farm Small Farm Smart Daily  The Growing Microgreens Podcast  The Urban Farmer Podcast  The Rookie Farmer Podcast  In Search of Soil Podcast Check out Diego's books:  Sell Everything You Grow on Amazon   Ready Farmer One on Amazon **** Modern Grower and Diego Footer participate in the Amazon Services LLC. Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.

In 1971, the National Cancer Act transformed cancer into a national research priority. More than 50 years later, the next frontier is no longer defined solely by scientific discovery, but by how quickly knowledge, lived experience, and patient voices can reshape healthcare itself.The concluding chapter of The Cancer Mavericks: A History of Survivorship explores how the cancer advocacy movement continues to evolve in an era of digital communities, social media, precision medicine, and grassroots activism. Building on the work of pioneers such as Mary Lasker, Rose Kushner, and the generations of survivors who followed, today's advocates are expanding the movement beyond awareness to demand health equity, trusted information, patient-centered research, and meaningful representation in healthcare decision-making.The episode examines how technology has transformed advocacy from local support groups into global communities capable of organizing in real time. Researchers, policymakers, nonprofit leaders, and survivors reflect on the growing influence of digital storytelling, online education, and peer-to-peer networks that connect patients across diagnoses, generations, and geographic boundaries. At the same time, they acknowledge new responsibilities: ensuring accurate medical information, combating misinformation, protecting trust, and keeping patients at the center of innovation.The story also looks ahead to the next generation of advocates. Young leaders are applying lessons learned from decades of cancer activism while drawing inspiration from broader movements for social justice, public health, and community organizing. Their work reflects a simple but enduring truth: meaningful change rarely begins inside institutions. It begins when ordinary people refuse to accept that the system cannot improve.Cancer survivorship has never been a finished story. Every generation inherits the progress achieved by those who came before while confronting challenges uniquely its own. The future of survivorship will be shaped not only by scientific breakthroughs, but by those willing to listen, organize, educate, and ensure that every patient's voice helps define what comes next.RELATED LINKSNational Cancer Institute⁠Cancer Moonshot⁠Centers for Disease Control and Prevention | Division of Cancer Prevention and Control⁠HopeLab⁠Tigerlily Foundation⁠Stupid Cancer⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this special bonus episode, we join American Medieval with host Matthew Gabriele, a professor of medieval studies and who knows about a LOT of history that we don't. We're there to chat with Matt about some new science research surrounding the Turin Shroud — a cloth that many Christians believe was used to wrap Jesus after he was killed. The debates over this artifact are fascinating and the science only adds to it! So if you like science, you like science history, you like a little controversy, you're going to love this episode. American Medieval is a podcast about the Middle Ages, but with an American twist. Each week, Professor Matthew Gabriele is joined by expert guests to explore either some fascinating part of the medieval world, or some way Americans have used this period to help them understand themselves.Matthew Gabriele is a professor of Medieval History and an elected Fellow of the Royal Historical Society (UK). In addition to hosting the podcast "American Medieval," he's the co-author of the books The Bright Ages: A New History of Medieval Europe (Harper Books, 2021), and Oathbreakers: The War of Brothers that Shattered an Empire and Made Medieval Europe (Harper Books, 2024). His new book, Violence: A Christian History, will be out with WW Norton in late 2027/ early 2028.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

S1E9: Caris Life Sciences Series Part 3 of 3: The Future: AI and Large-scale Molecular Data Shaping Next-Generation Oncology Host Shahid Shah with his guest Dr. Milan Radovich, Senior VP and Chief Scientific Officer at Caris Life Sciences To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Hercules Capital provides senior secured loans to high-growth, venture capital-backed companies across technology and life sciences. Since its inception in 2003, Hercules has committed more than US$28 billion to more than 700 companies and works with more than 1,000 leading venture capital and private equity firms. In this episode of Connected With Latham, Haim Zaltzman, Global Vice Chair of Latham's Emerging Companies & Growth Practice, sits down with Scott Bluestein, Chief Executive Officer and Chief Investment Officer of Hercules Capital, to discuss Hercules' investment approach, the role of venture debt in the current market, and how AI could shape the future of technology and life sciences markets.   This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York's Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York's Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200

Single-celled marine organisms called foraminifera may be microscopic, but they've had a massive impact on life on Earth. They also leave behind intricate shells that have become part of a fossil record stretching back more than 500 million years. Today, they're one of the most powerful tools scientists have for reconstructing Earth's past climates, helping us put the current (alarming) state of our warming planet into context.Check out Pale Blue pod here or wherever you listen to podcasts!A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In 1987, Mary P. Lovato, a member of Kewa Pueblo in New Mexico, was diagnosed with acute leukemia. To receive a bone marrow transplant, she had to travel more than 800 miles from home because specialized cancer care was unavailable through the Indian Health Service. When she returned, she discovered another obstacle: many in her community feared cancer so deeply that they avoided speaking about it altogether.This episode examines how cancer survivorship exposed profound inequities in the American healthcare system. Long before health equity became a national priority, advocates from underserved communities were confronting disparities rooted in geography, poverty, racism, language, underfunded healthcare systems, and historical mistrust of medical institutions. Their work demonstrated that scientific advances alone cannot improve survival if patients cannot reach, afford, or trust the care available to them.The story follows pioneers including Mary P. Lovato, who built the first national Native-led cancer support and education program for Indigenous communities, and Maimah Karmo, founder of the Tigerlily Foundation, whose breast cancer diagnosis inspired a movement to improve early detection, clinical trial participation, and representation for Black women. Their advocacy challenged longstanding barriers to culturally competent care while highlighting persistent inequities in access to screening, fertility preservation, navigation, and innovative treatments.The episode also explores why diversity in clinical research matters. For decades, many cancer clinical trials disproportionately enrolled White patients, limiting both access to promising therapies and the scientific understanding of how treatments perform across different populations. Researchers, patient advocates, and community leaders responded by redesigning outreach, improving patient navigation, reducing logistical barriers, and insisting that affected communities help shape the research itself.Cancer survivorship cannot be measured solely by scientific breakthroughs. It also depends on whether every patient has a meaningful opportunity to benefit from them. The pursuit of health equity remains one of the defining challenges and enduring responsibilities of modern oncology.RELATED LINKSNational Cancer Institute | Cancer Health Disparities⁠Indian Health Service⁠Tigerlily Foundation⁠National Cancer Institute | Cancer Clinical Trials⁠American Indian Cancer Foundation⁠Abramson Cancer Center | University of Pennsylvania⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Title: Food: The Ultimate Messenger  In this episode, we're looking at a warming world through a lens you may not expect: your dinner plate. Our guest is Mike Hoffmann, who has spent his career helping people understand the impacts of carbon pollution through the foods we all love and need. Mike has written on the subject for outlets including The Hill, Fortune, Medium, and USA Today, and is the lead author of Our Changing Menu: Climate Change and the Foods We Love and Need, published by Cornell Press in 2021. He's also delivered a TEDx Talk, "Climate Change: It's Time to Raise Our Voices," and has given more than 150 related talks over the course of his career. Mike grew up on a one-cow dairy farm, served in the Marines during the Vietnam War, and went on to hold multiple leadership roles at Cornell's College of Agriculture and Life Sciences, where he now holds the title of Professor Emeritus. As he puts it, he intends to keep telling this story for as long as he can.  The conversation opens with a snapshot of where things stand this fall with extreme weather, from wildfires and rising heat to the incoming El Niño, setting the stage for the deeper conversation about food. From there, Mike explains why he chose food as his entry point into this story rather than energy, sea level rise, or extreme weather, and what makes it such a powerful and relatable way to reach people. He and host Shannon Maganiezin dig into how food itself is changing due to excess greenhouse gases (GHGs), including troubling shifts in nutritional quality, the vitamins, proteins, and essential minerals that our diets depend on.  Mike also shares a story about pizza, one he's found to be a surprisingly effective way to illustrate the far-reaching effects of a warming climate on the foods we love, drawn from the many presentations he's given on the topic. The discussion turns to his teaching at Cornell, where he leads a course called Using the Power of Food to Confront Climate Change, and what he's learned from working with the next generation on these issues. The episode closes on a call to action: Mike's belief that food is the ultimate messenger for telling this story, and the potential for real change if more people start talking about and sharing it, including producers, food media, consumer groups, and chefs.  Tune in for a conversation that reframes carbon and other GHG pollution as something we all encounter three times a day and hear why one of the field's most experienced voices believes food may be our best tool yet for getting people to listen.   

Notes: Ms. Aybar traces her interest in criminal justice, government and politics back to childhood. She recalls her father having her choose a current event from the Sunday newspaper and then discussing it with him, and says she already knew by seventh grade that she wanted to attend John Jay College of Criminal Justice. Her route into cybercrime came through advertising and political campaigns. As digital advertising became increasingly important, she encountered problems with advertisements being directed toward bots rather than people and became involved in applying fraud-prevention techniques to campaigns. This experience sparked a wider interest in cybercrime. After beginning her PhD, Ms. Aybar worked on a research assignment involving USAID and DAI focused on enhancing Ukraine's cybersecurity posture. The work led her further into the national-security side of cybersecurity and into studying nation-state, non-state and other cyber actors. Ms. Aybar and her dissertation chair, Dr. Rob T. Guerette, used environmental criminology and rational choice theory to examine whether state-sponsored and non-state cyber actors demonstrate different behavioural signatures. Rather than focusing only on the tools used in an attack, the approach considers the choices attackers make around risk, reward, effort, visibility, operational security and what they are ultimately trying to accomplish. The study uses data from the European Repository of Cyber Incidents (EuRepoC), allowing the researchers to look for patterns across a large number of publicly documented cyber incidents over time. Ms. Aybar notes that this scale is useful, but also stresses that the data only represent incidents that are visible, recorded and attributable rather than the full universe of cyber activity. Changes in the threat landscape, actor names and APT naming conventions also create challenges for classification and consistency. The clearest distinction in the study was that non-state actors were more associated with high-visibility and immediate-impact activity, including ransomware, disruption, doxxing and publicly confirming responsibility for an attack. State-sponsored or state-affiliated actors were more associated with lower-visibility strategic activity, particularly data theft and reduced operational disruption. From a rational choice perspective, Ms. Aybar suggests these differences reflect different incentives. Non-state actors may benefit from visibility, pressure or immediate financial gain, while state-linked actors may have reasons to preserve access, avoid attention and quietly collect intelligence or strategically valuable data. She emphasizes that, regardless of the category of actor, there are still people behind the screens making these choices. Not all of the study's expectations were supported. The researchers expected state-sponsored actors to be more likely to target state and political systems, but this was not supported in their first theoretically guided model. Ms. Aybar suggests this may reflect strategic indirection: a state-linked actor can pursue a state-level objective by targeting contractors, universities, infrastructure dependencies, supply-chain intermediaries or private companies rather than attacking a government agency directly. Ms. Aybar's planned dissertation consists of three studies. The first will develop behavioural baselines for state-linked cyber operations associated with China, Iran, North Korea and Russia and compare their operational and visibility patterns. The second will examine time to public attribution and whether behavioural characteristics are associated with how quickly an actor is publicly named. Her third dissertation study will examine ransomware crime scripts in the biotechnology and life sciences sector compared with general enterprise cases. The aim is to identify points in the ransomware process where situational crime-prevention techniques could potentially disrupt an attack. This work has also led Ms. Aybar toward the emerging area of cyber biosecurity. She is interested in what happens when cyber threats intersect with biological data, laboratory systems, pharmaceutical research, AI and the wider bioeconomy, approaching these issues from a cybercrime and national-security perspective. About our guest: Priscilla F. Aybar, M.A. Florida International University — International Crime and Justice PhD Program https://ccj.fiu.edu/people/ph.d.-students/ Papers or resources mentioned in this episode: Aybar, P. F., & Guerette, R. T. (2026). Rational choices in cyberspace: Quantitative insights into targeting and attack behavior among cyber offenders. Journal of Criminal Justice, 103, 102621. https://doi.org/10.1016/j.jcrimjus.2026.102621 Pixalate & The Democratic Congressional Campaign Committee (DCCC): How the DCCC used Pixalate to reduce ad fraud A case study featuring Ms. Aybar's work using invalid-traffic detection and advertising analytics to reduce ad fraud in political digital campaigns. https://www.pixalate.com/case-study-dccc-ad-fraud-protection European Repository of Cyber Incidents (EuRepoC) https://eurepoc.eu/database/

The sudden emergence of AI models for all sorts of healthcare procedures, along with advanced hardware such as NVIDIA's GPU processors, creates questions for healthcare practices that want to improve outcomes and costs with these technologies. In a recent video interview, Dan Schneider, Enterprise Platforms Product Specialist at NVIDIA, and Sandra Colner, GM Global Healthcare & Life Sciences at Dell Technologies dove into these important topics and shared some key insights as healthcare leaders navigate AI in their organization.Learn more about NVIDIA: https://www.nvidia.com/en-us/Learn more about Dell Technologies: https://dell.com/HealthcareHealthcare IT Community: https://www.healthcareittoday.com/

Microsoft's Vision For Scaling AI in Healthcare Mary Varghese Presti, Corporate VP of Microsoft Health and Life Sciences, discusses where consumer experience, nursing, and AI are colliding to create some interesting tailwinds for patients and clinicians.  All that, plus the Flava of the Week about Reach3's new consumer health survey. What does the survey say about the use of digital health and wellness tools, and how does it help us to look at the data through the consumer lens?  Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In 2000, Katie Couric underwent a live colonoscopy on national television following the death of her husband, Jay Monahan, from colorectal cancer at age 42. The broadcast demystified a procedure many Americans feared, led to an estimated 20% increase in colonoscopy screenings, and became one of the clearest examples of how public storytelling can change healthcare behavior.This episode examines how celebrities, journalists, filmmakers, and entertainers helped reshape the public conversation about cancer during a period when survivorship was becoming increasingly visible. As breakthroughs in targeted therapies, immunotherapy, and early detection allowed more people to live beyond cancer, public figures used their platforms to encourage screening, reduce stigma, and accelerate research. Their influence extended far beyond awareness campaigns, helping transform cancer from a private diagnosis into a national public health conversation.Central to this story is Laura Ziskin, the Hollywood producer behind Pretty Woman and the Spider-Man films, whose metastatic breast cancer diagnosis inspired the creation of Stand Up To Cancer. Working alongside Couric and leaders from entertainment, journalism, and biomedical research, Ziskin championed a new funding model that required multidisciplinary scientific collaboration, helping accelerate discoveries that contributed to multiple FDA-approved cancer therapies. The episode also highlights the advocacy of actor Patrick Dempsey, whose family's experience with ovarian cancer led to the creation of the Dempsey Center, expanding support for patients and caregivers beyond medical treatment.The story also asks what celebrity advocacy often leaves unsaid. Financial toxicity, caregiver burden, chronic pain, mental health, and the long-term effects of treatment rarely receive the same attention as dramatic diagnoses or breakthrough cures. As cancer survivorship continues to evolve, the greatest challenge may not be convincing people to care about cancer, but helping them understand what it truly means to live with and beyond it.RELATED LINKSStand Up To Cancer⁠Katie Couric Media⁠Dempsey Center⁠American Association for Cancer Research⁠National Cancer Institute⁠Dana-Farber Cancer Institute | Adult Survivorship Program⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What does responsible AI look like in practice? In this episode, we explore AI governance, AI risks, ethical AI, and how businesses can use artificial intelligence responsibly to create value without losing trust.  KEY MOMENTS    02:33 What is the current state of AI? 06:32 What are the biggest AI risks and threats? 11:00 How can AI become a force multiplier? 15:17 What is the Global AI Association? 18:00 How to connect with the guest  In this episode of the FIT4Privacy Podcast, host Punit Bhatia speaks with Pasquale Falconio from the Global AI Association about responsible AI, AI governance, generative AI, and the real business impact of artificial intelligence. They discuss where AI stands today, what makes AI risky, and how organizations can adopt AI in a way that is ethical, practical, and trustworthy.You will learn why AI itself is not the problem, why governance and human oversight matter, and how AI can support people as a super-assistant instead of replacing them. If you are interested in responsible AI, AI ethics, AI regulation, digital trust, or business transformation with AI, this conversation offers practical insights you can apply immediately.

In this episode of Tiny Show and Tell Us, we discuss new blood tests and research into blood biomarkers that could make diagnosing endometriosis faster and less invasive. Next, we unpack subsynchronous resonance, a phenomenon that can damage power infrastructure, and is gaining new attention with so many AI data centers being built across the country. Then we hear from guest Emily Schneider who shares some delicious (maybe? You be the judge!) new research where scientists have engineered yeast to convert plastic waste and agricultural leftovers into cookies.We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org or fill out this form with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

BUFFALO, NY — August 26, 2026 — A new #review was #published in Volume 18 of Aging on August 10, 2026, titled “Metformin at the convergence of aging and longevity.” The review was authored by Jarra Manneh, May Alasmar and Nady El Hajj from the College of Health and Life Sciences at Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar. Corresponding author Nady El Hajj is also affiliated with the College of Science and Engineering at Hamad Bin Khalifa University, Doha, Qatar. Metformin has been used for decades as a first-line treatment for type 2 diabetes, but increasing interest in geroscience has raised a broader question: could this widely used metabolic drug also influence the biological processes that drive aging? The review brings together evidence from cellular studies, animal models, human observational research, and clinical trials examining how metformin interacts with multiple hallmarks of aging. A central mechanism involves AMP-activated protein kinase (AMPK), a major cellular energy sensor. By inhibiting mitochondrial complex I and altering cellular energy balance, metformin can activate AMPK, triggering downstream effects that include suppression of mechanistic target of rapamycin (mTOR) signaling, increased autophagy and mitochondrial biogenesis, and reduced oxidative stress. Metformin also improves insulin sensitivity and reduces hepatic gluconeogenesis, connecting its established metabolic effects with nutrient-sensing pathways involved in aging biology. Full press release - https://www.aging-us.com/news-room/metformin-emerges-as-a-promising-candidate-at-the-intersection-of-aging-and-longevity DOI - https://doi.org/10.18632/aging.206407 Corresponding author - Nady El Hajj - nelhajj@hbku.edu.qa Abstract video - https://www.youtube.com/watch?v=5Ws-x8e1klI Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206407 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, metformin, AMPK, mTOR, epigenetic modifications To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

In 2006, a landmark report titled Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer confirmed what young survivors had been saying for years. While survival rates for children and older adults had steadily improved, adolescents and young adults had experienced decades of stalled progress. They had become cancer's lost generation.This episode explores how young adult survivors transformed their shared isolation into one of the most influential grassroots movements in cancer advocacy. Diagnosed during the years typically devoted to education, careers, relationships, and starting families, patients between the ages of 15 and 39 confronted challenges that extended far beyond treatment. Fertility preservation, sexual health, employment, financial toxicity, insurance, and long-term quality of life were rarely discussed in oncology clinics, leaving many to navigate survivorship alone.The episode follows advocates including Tamika Felder, Lindsay Avner, Heidi Adams, Doug Ulman, and Dr. Archie Bleyer, whose research and advocacy fundamentally changed how medicine understands adolescent and young adult cancer. Through organizations including Planet Cancer, Fertile Hope, the Lance Armstrong Foundation, and later Stupid Cancer, survivors built online communities, educational resources, conferences, and national partnerships that challenged long-standing assumptions about cancer care. Their work helped establish fertility preservation as a standard discussion before treatment, expanded research dedicated to adolescent and young adult oncology, and elevated quality of life as a critical clinical outcome alongside survival.The movement also demonstrated the power of lived experience to reshape medicine. Survivors became researchers, educators, nonprofit founders, and policy advocates, insisting that cancer care account not only for years of life saved, but for the lives patients hoped to build afterward.What began as a search for peers evolved into a national movement that permanently transformed adolescent and young adult oncology. Today, dedicated research programs, clinical fellowships, survivorship resources, and patient advocacy organizations continue to build on the foundation these young cancer mavericks created.RELATED LINKSNational Cancer Institute | Adolescent and Young Adult (AYA) Cancer Program⁠Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer⁠American Society of Clinical Oncology | Fertility Preservation Guidelines⁠Stupid Cancer⁠Livestrong Foundation⁠Journal of Adolescent and Young Adult Oncology⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Matters Microbial #137: The Living Skin of Our Planet August 25, 2026 Today Dr. Estelle Couradeau, Assistant Professor in the Department of Ecosystem Science and Management and the Huck Institutes of the Life Sciences at the Pennsylvania State University,  joins the quality quorum today to discuss the role that the soil microbiome can play in terms of agriculture, moderating temperature, and protecting specific environments.   Host: Mark O. Martin Guest: Estelle Couradeau Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode The Erskine Foundation fellowship website. An overview of Paenibacillus.   An article discussing the fascinating colonial morphology often found with Paenbacillus.  A blog post that demonstrates that the odd appearance of Paenibacillus can be used by other microbes for dispersal!  Dr. Jo Handelsman's essential book, "A World Without Soil." A fine video describing the soil microbiome. The complexity of soil with regard to where and how microbes can live. Science journalist Carl Zimmer's indispensable essay likening the microbial ecology of lakes to the human body:  "The Human Lake." An overview of dormancy in microbes. The "BonCat" (bio-orthogonal non-canonical amino acid tagging) technique for detecting living microbes in a sample without cultivation. An overview of flow cytometry in microbiology. An essay suggesting that marine bacteria are involved in the production of clouds. An article about climate change and microbes. An article about cyanobacteria and "sunscreen." A review article about the "biocrust" concept. A video overview of beautiful and fascinating microbial fossils:  stromatolites. A video by Dr. Couradeau describing her research. Articles by Dr. Couradeau and colleagues asking which microbes are active in soil:  here, here, and here. Articles by Dr. Couradeau and colleagues asking if microbes can change the temperature of a desert:  here and here. Articles by Dr. Couradeau and colleagues that explore the hidden microbiomes of Andean páramo wetlands:  here and here. Dr. Couradeau's faculty website. Dr. Couradeau's research website. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

Nicole Locklin for US Congress is an attorney with more than a decade of legal experience, most recently serving as Lead Commercial Legal Counsel for Healthcare and Life Sciences at Databricks. She grew up in a town of about a thousand people in rural Oklahoma, where her parents ran a crop dusting business. A first generation college graduate who relied on student loans to earn her law degree, Nicole is now running as a Democrat for U.S. Congress in Florida's 26th District, challenging a twenty plus year incumbent and making the case that working families in South Florida deserve a representative who actually works for them.We talked about what it has actually felt like to leave a legal career and step into a congressional race with no political background, the affordability crisis Nicole keeps hearing about on doorsteps across South Florida where homeowner's insurance averages $8,000 a year and a one bedroom apartment can run nearly $3,000 a month, and why Nicole believes corruption and corporate money in politics is the root cause blocking progress on every other issue families care about. We also discussed the gerrymandering that reshaped FL-26, why Nicole sees the seat as genuinely flippable, and what it means to run a grassroots campaign in a state where the political establishment has spent years trying to erase Democratic votes.Connect with Nicole: Website | Instagram | Substack If you're looking to unleash your potential, find your personal, professional, or political fire, and to connect with a community who is doing the same, click here to learn more. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit shannonwatts.substack.com/subscribe

Your thyroid may be small, but it plays a major role in your energy, metabolism, hormones, mood, and overall health. In this conversation, Dr. Michelle Robin and Bayleigh Soza sit down with Dr. Alicia Johnson to discuss common thyroid conditions, why symptoms can occur even when labs appear normal, and the importance of looking beyond surface-level answers.  Together, they explore how stress, nutrition, blood sugar, hormones, vitamin D, and environmental factors can impact thyroid function. Dr. Johnson shares practical strategies for supporting thyroid health and explains how small, proactive steps can help prevent bigger health challenges in the future.   Key Takeaways:   Your thyroid influences every cell in your body, impacting energy, metabolism, mood, hormones, digestion, and overall health.   Thyroid symptoms can occur even when standard thyroid lab results appear normal, making comprehensive testing important.   Stress, blood sugar imbalances, environmental toxins, hormone fluctuations, and nutrient deficiencies can all affect thyroid function.   Prevention matters—tracking health markers early can help identify issues before they become major health challenges.   Simple lifestyle habits such as eating whole foods, maintaining healthy vitamin D levels, managing stress, and supporting key nutrients can improve thyroid and endocrine health.   We couldn't highlight incredible stories like this without the support of our sponsor, CommunityAmerica Credit Union. Thank you for helping us promote connection, well-being, and stronger communities. If you're looking for trusted financial wellbeing resources, we invite you to connect with their team and take the next step toward greater financial confidence.  About Dr. Alicia Johnson:  Alicia Johnson is a licensed Doctor of Naturopathic Medicine. Her areas of expertise include medical weight loss, hormone balance, fatigue, anti-aging, and mood disorders.  Dr. Johnson has a passion for getting to know her patients and working together as a team to address even the most complicated health concerns.  Dr. Johnson utilizes natural, non-invasive therapies to treat many common conditions such as menstrual irregularities, menopausal symptoms, depression, anxiety, obesity, infertility, low testosterone, fatigue, digestive problems, and many other chronic conditions.  Dr. Johnson is a graduate from Southwest College of Naturopathic Medicine in Tempe, AZ. She received her acupuncture training from the Phoenix Institute of Herbal Medicine and Acupuncture. Prior to medical school, she received her Bachelors of Science in Life Sciences with a secondary degree in Gerontology, the study of aging. Dr. Johnson's patients are treated individually with a combination of Bioidentical Hormone Replacement recommendations, acupuncture, nutritional supplementation, botanical medicine, dietary counseling, homeopathy, and lifestyle counseling. This unique, individualized approach is effective for improving the outcome of almost any chronic health condition because many chronic diseases simply do not respond well to simple pharmaceutical treatment.  Connect with Dr. Alicia Johnson at:  https://aspirehealthkc.com/ Connect with Dr. Michelle and Bayleigh at:  https://smallchangesbigshifts.com  hello@smallchangesbigshifts.com  https://www.linkedin.com/company/smallchangesbigshifts  https://www.facebook.com/SmallChangesBigShifts  https://www.instagram.com/smallchangesbigshiftsco  https://www.youtube.com/@smallchangesbigshiftsco    Thanks for listening!  Thanks so much for listening to our podcast! If you enjoyed this episode and think that others could benefit from listening, please share it using the social media buttons on this page.  Do you have some feedback or questions about this episode? Leave a comment in the section below!  Subscribe to the podcast  If you would like to get automatic updates of new podcast episodes, you can subscribe to the podcast on Apple Podcasts or Stitcher. You can also subscribe in your favorite podcast app.  Leave us an Apple Podcasts review  Ratings and reviews from our listeners are extremely valuable to us and greatly appreciated. They help our podcast rank higher on Apple Podcasts, which exposes our show to more awesome listeners like you. If you have a minute, please leave an honest review on Apple Podcasts. 

S1E8: Caris Life Sciences Series - Part 2 of 3: The Access: Liquid Biopsy and Expanding Access to Precision Oncology Host Shahid Shah with his guest Joseph C. Murray, MD, PhD, is Senior Medical Director at Caris Life Sciences. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In 2006, the Institute of Medicine published From Cancer Patient to Cancer Survivor: Lost in Transition, concluding that millions of Americans were surviving cancer only to find themselves navigating a healthcare system unprepared for life after treatment. The report challenged oncology to recognize that curing cancer was not the end of care, but the beginning of survivorship.This episode explores how the growing cancer survivorship movement exposed the long-term consequences of cancer treatment that medicine had largely overlooked. As survival rates improved following the National Cancer Act of 1971, millions of survivors faced chronic fatigue, neuropathy, infertility, cognitive impairment, financial hardship, employment discrimination, anxiety, depression, and post-traumatic stress. These were not rare complications. They became defining features of survivorship for many patients.Drawing on the work of oncologist Dr. Patricia Ganz, survivor advocate Ellen Stovall, and researchers, clinicians, and survivors across the country, the episode examines how survivorship research expanded beyond recurrence and mortality to include quality of life, psychosocial care, rehabilitation, and long-term follow-up. Their efforts helped establish survivorship care plans, multidisciplinary survivorship clinics, and a broader understanding that cancer affects every aspect of a person's life long after treatment ends.The episode also confronts persistent inequities in survivorship care. Insurance coverage often ends when treatment stops, supportive services remain inconsistent, financial toxicity continues to drive medical hardship, and racial, geographic, and socioeconomic disparities still influence who receives comprehensive follow-up care. For many survivors, finishing treatment simply marks the beginning of another struggle.Modern oncology increasingly recognizes that surviving cancer is measured by more than years of life. It is also measured by quality of life, dignity, access to care, and the ability to rebuild a future after treatment. That evolution remains one of the most significant legacies of the cancer survivorship movement.RELATED LINKSNational Academy of Medicine | ⁠From Cancer Patient to Cancer Survivor: Lost in Transition⁠National Cancer Institute Office of Cancer Survivorship⁠American Society of Clinical Oncology | Survivorship Compendium⁠CancerCare⁠HopeWell Cancer Support⁠National Coalition for Cancer Survivorship⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Outcome Based Selling is becoming more important as AI makes technology services faster. But according to Luiz Cieslak, faster execution creates a problem: neither fixed scope nor time and materials necessarily rewards both sides fairly. If AI can turn a six-month project into three months, who actually benefits? In this conversation with Harry Kendlbacher, Luiz Cieslak, SVP of Healthcare & Life Sciences at CI&T, explores risk sharing, AI-driven delivery, and why changing the commercial model also requires a different sales mindset. For Luiz, consultative selling cannot simply be another item in the sales playbook. Sellers need to understand what customers are actually trying to achieve, look beyond the initial ask, and build the right commercial construct around the outcome. What We Cover: • Why AI is challenging traditional fixed scope and time and materials models • How risk sharing can create a different kind of customer partnership • Why changing the commercial model requires a different sales mindset • Why consultative selling means understanding what is beyond the customer's initial ask • Why customer attention and mental bandwidth may be the real constraint in modern B2B selling ⏱️ Timestamps 00:00 Why AI Is Changing Technology Services 04:00 Fixed Scope vs. Time and Materials: Who Takes the Risk? 06:41 Why AI Changes the Economics of Traditional Models 08:01 Customer Pushback on New Commercial Models 15:22 Why Consultative Selling Has to Become Second Nature 19:52 Outcome Based Selling and the Value of Customer Attention About Luiz Cieslak Luiz Cieslak is the SVP of Healthcare & Life Sciences at CI&T, with extensive experience across the IT industry, including technology systems development, Agile methodologies, and global project and team management. He has worked with Fortune 50 companies in complex enterprise environments, with a focus on digital marketing engagements and process optimization. Connect with Luiz on LinkedIn: https://www.linkedin.com/in/luizcieslak/

Scientists spent decades searching for viruses by filtering out anything too large to be one. That strategy seemed to work well... until it didn't. When researchers discovered a microbe living inside an amoeba that looked like a bacterium but behaved like something else entirely, they uncovered a hidden world of giant viruses with massive genomes, unusual genes, and even their own viral parasites. In this episode, we dive into the discoveries that forced scientists to rethink what viruses are, how they evolve, and whether the rules historically used to define them still hold up.Check out Dreaming Against the Machine here or wherever you listen to podcasts!A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In 1967, breast surgeon Dr. Harold P. Freeman arrived at Harlem Hospital expecting to treat cancer. Instead, he confronted a healthcare system where poverty, racism, lack of insurance, and institutional barriers often determined who lived long enough to receive treatment. Patients frequently arrived with advanced disease, not because medicine lacked answers, but because access to care had failed them.This episode explores how cancer survivorship expanded beyond medical breakthroughs to include healthcare access, health equity, and organized advocacy. Building on the early work of the National Coalition for Cancer Survivorship (NCCS), it examines the recognition that surviving cancer depended not only on research, but also on whether patients could navigate a fragmented healthcare system.Freeman responded by creating one of the nation's first patient navigation programs at Harlem Hospital in 1990. Community-based navigators helped patients overcome practical barriers including insurance, transportation, appointments, communication, and fear. The model dramatically improved timely diagnosis and treatment, increased breast cancer survival in Harlem, and ultimately inspired the Patient Navigator Outreach and Chronic Disease Prevention Act of 2005, establishing navigation as a cornerstone of modern oncology care.The episode also follows cancer survivor Ellen Stovall, whose leadership transformed survivorship into a national policy movement. Through the NCCS, she united advocates across cancer types, fought for insurance protections, expanded access to clinical trials, helped shape the creation of the Office of Cancer Survivorship at the National Cancer Institute, and organized the landmark 1998 National March for Cancer Survivorship in Washington, D.C. Her work reframed survivorship as a public policy issue rather than a personal experience.Together, Freeman and Stovall demonstrated that scientific progress alone could not eliminate disparities in cancer outcomes. Their work established two enduring principles that continue to shape oncology today: patients need someone to help them navigate care, and survivors must have a voice in the policies that govern it. Modern cancer survivorship depends on both.RELATED LINKSNational Coalition for Cancer Survivorship⁠Harold P. Freeman Patient Navigation Institute⁠National Cancer Institute Office of Cancer Survivorship⁠Patient Navigator Outreach and Chronic Disease Prevention Act of 2005⁠American Cancer Society⁠Tuskegee Study Timeline | Centers for Disease Control and Prevention⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Welcome to a very, very, very special bonus episode of Out of Patients, and one unlike anything published on this feed before. For nearly 20 years, Matthew Zachary has handed these microphones to patients, caregivers, doctors, advocates, troublemakers, and people with something worth saying. This time, he handed them to his daughter. Hannah Greenzweig grew up around this show, and now she has commandeered the studio with 3 of her wonderfully creative high school friends to talk about something they built entirely themselves. There is an enormous amount of Dad Pride baked into this episode, along with the strange and wonderful realization that sometimes your kid grows up, takes your chair, takes your microphone, and produces a better show without you.Hannah Greenzweig, Michael Aidinov, Gwendolyn Baldini, and Astronomy are student artists from the Roundabout Youth Ensemble at James Madison High School in Brooklyn. Working alongside teaching artists from Roundabout Theatre Company, they spent a school year creating an original play from the ground up, writing every scene, developing every character, and producing the performance themselves.Instead of discussing a Broadway production, they dissect one they invented.Their play, Subject Matter, began with a room full of improbable ideas. Murderous bounce houses, pirate family sagas, underwater adventures, courtroom dance battles, and birthday parties at math museums all competed before the group settled on an absurd rivalry between New York's fictional History Museum and Math Museum. From there, they built a fully staged comedy about institutional competition, sabotage, oversized personalities, and the unexpected discovery that history and mathematics need each other more than either side wants to admit.The conversation pulls back the curtain on a creative process most audiences never see. The students explain how scenes evolved through constant rewrites, how characters emerged from improvisation, how costumes came together with last minute ingenuity, and how rehearsals often collapsed into uncontrollable laughter. They recount cutting favorite ideas, solving production problems with limited resources, and trusting each other enough to keep rewriting until the story worked.The episode also captures something harder to script: teenagers speaking honestly about collaboration without adults translating their experience. They celebrate classmates who stepped into unexpected roles, teachers who quietly held the production together, and the strange joy of creating something that exists only because everyone showed up.It is a conversation about theater, friendship, education, creativity, and what happens when 4 young artists get the microphones and the adults get out of the way.RELATED LINKSRoundabout Theatre CompanyRoundabout Youth EnsembleJames Madison High SchoolFEEDBACKLike this bonus episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Welcome to the Podcast of Southwest Bible Fellowship in Tempe, Arizona. WHO ARE WE? • We are a group of people who are committed to living the grace life as set forth by the apostle of the Gentiles, the Apostle Paul. • We come together to study our Bibles, and yes, we believe we have God's perfect Word in the King James Bible. It and it alone is our final authority in all matters of faith and practice! • We do not come together and study our Bibles for the intent of being smarter than others. We understand that knowledge for the sake of knowledge is purely vain and serves no Godly purpose. • We do come together and study our Bibles for the intent of knowing our Lord Jesus Christ and the power of His resurrection. (Philippians 3:10) • We do come together and study our Bibles to understand that we have been crucified with Christ; nevertheless we live; yet not us, but Christ liveth in us: and the life which we now live in the flesh, we live by the faith of the Son of God, who loved us and gave himself for us. (Galatians 2:20) • We do come together and study our Bibles to understand that because Jesus Christ shed His blood for us and we should not live for ourselves but for Him, who died for us and rose again. (2 Cor. 5:15) • We do not claim to have attained to these lofty goals, but we press toward the mark of the prize of the high calling of God in Christ Jesus. (Philippians 3:14) You can donate to this ministry through www.butnow.org and the PayPal button on the homepage.

When patient data becomes the raw material for AI, who actually governs it and for whose benefit? Mir Masud-Elias, Counsel, Arnold & Porter, and Mala Sahai, Senior Director, Intellectual Property and Legal Affairs, Gladstone Institutes, discuss the shift from data sharing as an administrative function to data licensing as a regulated risk transfer. They cover the multiple regulatory regimes (from state to federal to international); data types and classification risks; ownership, control, and governance; the three HIPAA pathways; core contract architecture; AI clauses, bias, validation, audit, and lifecycle risk; federated learning; patent versus trade secret strategy; and direct versus indirect monetization. Mir authored a Health Law Weekly article on this topic.Watch this episode: https://www.youtube.com/watch?v=IkKVzg0VPJMRead Mir's Health Law Weekly article: https://www.americanhealthlaw.org/content-library/health-law-weekly/2026/april/3/who-owns-the-pulse-what-health-system-lawyers-need Essential Legal Updates, Now in AudioAHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Comprehensive members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.Stay At the Forefront of Health Legal EducationLearn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/. 

A man is struck by a car on the streets of Los Angeles. In the emergency department, a CT scan ordered to look for traumatic injuries reveals something nobody expected: a mass in his colon. Days later, sitting across from Dr. Belinda Waltman, he calls the accident “a blessing in disguise.” Then he changes the subject. He is less worried about cancer than about whether he can afford to miss another day of work. In this season finale of Standard Deviation, host Dr. Oliver Bogler explores what happens when biomedical science collides with the realities of the healthcare safety net. Dr. Waltman, a primary care physician in Los Angeles County, specializes in expedited cancer workups for uninsured and underinsured patients. Every diagnosis arrives carrying another set of questions about housing, transportation, food insecurity, wages, and survival that rarely appear in medical records or scientific literature. For years, Waltman carried those stories without knowing how to bring them into the academic record. As a full-time clinician without a research lab, grant funding, or publication pipeline, she faced barriers familiar to many working scientists and physicians whose most important observations happen outside traditional research settings. With support from the Life Science Editors Foundation's JEDI program, those experiences became The Margins Matter, a narrative medicine essay published in JAMA that argues the social realities surrounding cancer care are not background details. They are part of the disease itself. Bogler traces how editorial mentorship transformed lived clinical experience into published scholarship while asking a larger question about who gets to shape the scientific record. The conversation examines cancer care, Medicaid, health-related social needs, medical publishing, and the structural incentives that determine which stories become evidence and which disappear from view.The result is a conversation about documentation, visibility, and why the margins of medicine often determine who survives long enough to benefit from its advances.RELATED LINKSDr. Belinda Waltman⁠The Margins Matter | JAMA⁠The Margins Matter | PubMed⁠Life Science Editors Foundation⁠FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Tiny Show and Tell Us, we explore how scientists are using evolutionary methods to reconstruct the history of folktales like Little Red Riding Hood, Beauty and the Beast, and Jack and the Beanstalk. Then guest Matt Gabriele, professor of medieval studies and host of the podcast American Medieval, shares his fascination with Greenland sharks, leading us into the science of radiocarbon dating, longevity genetics, and the ongoing debate over whether these elusive deep-sea predators truly live for 400 years or more.We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org or fill out this form with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

GLPs are everywhere right now — but do you actually know what they are or what they do? In this episode I break down the reality of GLP-1, what it is, how it works, and how your body already has the natural ability to activate it through a fasting-focused lifestyle. Whether you're considering the shot or just curious about how it all works, this episode gives you the full picture so you can make the best decision for your health and future. _____ Are you ready for real, compassionate support on your fasting journey from someone who has actually lived it? I've shed over 200 pounds through fasting and have maintained it through some of the hardest seasons of life. If you're tired of doing this alone, you don't have to anymore. Come find your people: The Fasting Support Club _____ REFERENCES Habener, J.F. (2004). The discovery of glucagon-like peptide 1. ScienceDirect — Molecular and Cellular Endocrinology. Retrieved from sciencedirect.com Mass General Brigham Newsroom. (2025). Joel Habener receives Breakthrough Prize in Life Sciences for contributions to GLP-1 medications. Retrieved from massgeneralbrigham.org Journal of Clinical Investigation. (2024). Joel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsen awarded Lasker Prize for pioneering work on GLP-1. Retrieved from jci.org Eng, J. (1992). Discovery of exendin-4 in Gila monster venom. VA Medical Center, Bronx, NY. Referenced in: PlexusDx. (2026). History of GLP-1 drugs: Complete timeline from exenatide to tirzepatide. Retrieved from plexusdx.com Fella Health. (2025). What is GLP-1 lizard venom: Gila monster discovery to diabetes drugs. Retrieved from fellahealth.com U.S. Food and Drug Administration. (2005). Approval of exenatide (Byetta) for type 2 diabetes. FDA Drug Approval Database. Acosta, A. & Ghusn, W. (2023). Semaglutide shown to be effective for weight loss in multicentre, one-year real-world study. European Congress on Obesity (ECO2023). Presented by Precision Medicine for Obesity Program, Mayo Clinic. Retrieved from eurekalert.org Mayo Clinic Press. (2026). Health benefits of semaglutide beyond weight loss. Retrieved from mcpress.mayoclinic.org National Institutes of Health / NCBI. (2024). Patient perceptions of Ozempic (semaglutide) for weight loss: Mixed methods analysis of online medication reviews. Retrieved from ncbi.nlm.nih.gov National Institutes of Health / NCBI. (2024). Evaluation of pre-treatment assessment of semaglutide users: Balancing the benefits of weight loss vs. potential health consequences. Retrieved from ncbi.nlm.nih.gov Fung, J. (2016). The Obesity Code: Unlocking the secrets of weight loss. Greystone Books. Fung, J. (2025). The Hunger Code: Resetting your body's fat thermostat in the age of ultra-processed food. Greystone Books.

In 1986, 23 survivors, physicians, nurses, attorneys, and community organizers gathered in Albuquerque, New Mexico, for a weekend that would permanently change the language and politics of cancer. Working late into the night, they debated not only strategy, but identity, ultimately declaring that from the moment of diagnosis, every person with cancer is a survivor.This episode traces the social and political forces that gave birth to the modern cancer survivorship movement. As advances in early detection and treatment allowed more people to live beyond cancer, survivors discovered that finishing treatment did not mean returning to normal life. Many faced employment discrimination, loss of insurance, social stigma, infertility, chronic health complications, and a healthcare system that viewed survival as the end of care rather than the beginning of a new chapter.Against the backdrop of the civil rights, disability rights, and community health movements of the 1960s and 1970s, physicians, activists, and survivors challenged medicine's paternalistic culture and demanded a greater voice in decisions affecting their lives. Central to this story are physician and survivor Dr. Fitzhugh Mullan, whose landmark 1985 essay, Seasons of Survival, redefined survivorship as a lifelong continuum, and community organizer Katherine Logan, whose determination united dozens of grassroots organizations into what became the National Coalition for Cancer Survivorship.The coalition's founding established principles that continue to shape oncology today. Survivors were no longer defined solely by disease or treatment outcomes. Their experiences became evidence. Their voices became essential to clinical research, healthcare policy, and patient advocacy. By redefining survivorship as an ongoing experience rather than a destination, the movement challenged medicine to recognize the lasting physical, emotional, financial, and social consequences of cancer.The ideas forged during that weekend in Albuquerque became the foundation of modern cancer survivorship. Nearly 40 years later, the coalition's defining principle, that survivorship begins at diagnosis, continues to influence cancer care, research, policy, and the way millions of people understand life after cancer.RELATED LINKSNational Coalition for Cancer Survivorship⁠National Cancer Institute Office of Cancer Survivorship⁠The New England Journal of Medicine⁠Americans with Disabilities Act (ADA.gov)⁠Library of Congress | Civil Rights History Project⁠White Coat, Clenched Fist by Fitzhugh Mullan⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode 82 - Matthew Whitty, former NHS England Director of Innovation, Research and Life Sciences and now Director of Commercial Partnerships at MDClone, discusses NHS data strategy, safe AI adoption and protecting patient privacy.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

S1E7: Caris Life Sciences Series - Part 1 of 3: The Science: Advancements in molecular profiling (WES + WTS) and impact on cancer care Host Shahid Shah with his guest James Hamrick, MD, MPH, Chairman of the Caris Precision Oncology Alliance™ (Caris POA). To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Welcome to the Podcast of Southwest Bible Fellowship in Tempe, Arizona. WHO ARE WE? • We are a group of people who are committed to living the grace life as set forth by the apostle of the Gentiles, the Apostle Paul. • We come together to study our Bibles, and yes, we believe we have God's perfect Word in the King James Bible. It and it alone is our final authority in all matters of faith and practice! • We do not come together and study our Bibles for the intent of being smarter than others. We understand that knowledge for the sake of knowledge is purely vain and serves no Godly purpose. • We do come together and study our Bibles for the intent of knowing our Lord Jesus Christ and the power of His resurrection. (Philippians 3:10) • We do come together and study our Bibles to understand that we have been crucified with Christ; nevertheless we live; yet not us, but Christ liveth in us: and the life which we now live in the flesh, we live by the faith of the Son of God, who loved us and gave himself for us. (Galatians 2:20) • We do come together and study our Bibles to understand that because Jesus Christ shed His blood for us and we should not live for ourselves but for Him, who died for us and rose again. (2 Cor. 5:15) • We do not claim to have attained to these lofty goals, but we press toward the mark of the prize of the high calling of God in Christ Jesus. (Philippians 3:14) You can donate to this ministry through www.butnow.org and the PayPal button on the homepage.

In 1971, President Richard Nixon signed the National Cancer Act, transforming cancer research with an unprecedented federal investment and launching what became known as the War on Cancer. The legislation did not emerge from scientific discovery alone. It was the culmination of decades of relentless advocacy by researchers, philanthropists, journalists, and patients who believed cancer demanded the same national commitment that had put astronauts on the Moon.This episode traces the origins of the cancer survivorship movement by returning to a time when cancer was rarely discussed in public, many physicians withheld diagnoses from their patients, and surgery offered few lasting cures. It follows the pioneering work of pathologist Dr. Sidney Farber, whose early chemotherapy research challenged conventional thinking, and Mary Lasker, whose political strategy, fundraising, and public campaigns helped transform cancer from a private tragedy into a national public health priority. Together, they built the coalition that reshaped federal support for oncology research and forever changed the relationship between science, government, and the American public.The story then turns to journalist and breast cancer survivor Rose Kushner, whose refusal to accept the standard one-step radical mastectomy challenged nearly a century of surgical dogma. Working alongside surgeon Dr. Bernard Fisher, Kushner helped bring evidence-based medicine to breast cancer treatment through randomized clinical trials that demonstrated less invasive surgery could achieve equivalent outcomes. Their efforts changed clinical practice, strengthened informed consent, and helped establish the principle that patients should participate in decisions about their own care.The breakthroughs explored in this episode extended far beyond new treatments. They redefined the role of patients in medicine, accelerated clinical research, and laid the foundation for modern cancer survivorship. The movement that followed would not simply help more people live longer. It would change what surviving cancer meant.RELATED LINKSNational Cancer Institute⁠National Cancer Act of 1971⁠American Cancer Society⁠Dana-Farber Cancer Institute⁠National Library of Medicine⁠The New England Journal of Medicine⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Long before cancer survivors organized into a movement, Hollywood had already shaped how Americans understood the disease. Films rarely used the word “cancer,” physicians often withheld diagnoses from patients, and the people who survived were almost nowhere to be found on screen.Recorded before The Cancer Mavericks: A History of Survivorship became a documentary series, this bonus conversation explores where the project first began. Matthew Zachary sits down with his mother, Roz Greenzweig, a retired educator and lifelong film enthusiast whose memories of classic cinema became an unexpected lens for understanding how cancer was portrayed throughout the twentieth century.Together, they revisit landmark films including Dark Victory, Love Story, and other iconic portrayals that reflected an era when cancer was treated as unspeakable, inevitable, and almost always fatal. Their conversation contrasts those carefully constructed Hollywood narratives with the lived reality of a family confronting a brain cancer diagnosis in 1995, revealing how popular culture both reflected and reinforced the fears surrounding the disease.The discussion also foreshadows many of the themes explored throughout the documentary series: the evolution of patient advocacy, the emergence of cancer survivorship, the role of caregivers, and the power of storytelling to influence public understanding. Before policy changed, before advocacy organizations grew into national movements, conversations like these were already challenging long-held assumptions about what cancer looked like and who had the right to tell its story.Consider this the prologue to The Cancer Mavericks. Before the movement found its history, it began with a family trying to make sense of the stories they had inherited.RELATED LINKSAmerican Cancer Society⁠National Cancer Institute⁠American Film Institute⁠ER (NBC)⁠50/50 (Official)⁠Chasing Life (ABC Family Archive)⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Questions? Email podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Digital, real, real, digital. It sounds simple, but it's rewriting how a warehouse gets designed.Joel Thomas has spent over a decade in the Intralogistics space and now leads OEM Sales Data Center and Life Sciences at Siemens. Markus Thiel just crossed the six month mark as Head of Intralogistics, after years on the manufacturing operations and supply chain side of the business.Chris caught up with both of them live in Atlanta during MODEX, over a Weiss beer and a pilsner at Halfway Crooks. They talk about what Intralogistics is, and how it's changed since the days of pallet jacks and conveyor belts.From there the conversation covers the industry engineer shortage, robotics, AGVs versus AMRs, why standardization is becoming such a hot topic among vendors, and what a warehouse looks like when it's designed digitally.In this episode, find out:How the day-to-day work of moving goods within a warehouse has changed over the past decadeThe shift to robotics, AGVs, and AMRs, and why orchestrating all of it is now the hard partWhy standardization is gaining ground even though flexibility with vendors used to be the priorityHow AI is being used to spot bottlenecks and predict maintenanceWhat edge computing means for a warehouseWhat it takes to build a digital twin, and why Siemens tests new technology in its own factory firstWhether a conveyor-less warehouse is realistic, and who's already exploring itWhy e-commerce has been the single biggest driver of growth in the industryWhat's next for the space, software-defined automation and the IT/OT layerEnjoying the show? Please leave us a review here. Even one sentence helps. It's feedback from Manufacturing All-Stars like you that keeps us going!Tweetable Quotes:"We want more individualized goods, and we want it faster and sooner, so that thing will not stop. It will further accelerate. It's great to see all the technology which is helping that development.” - Markus Thiel, Head of Intralogistics at Siemens“It was always about taking off your professional hat, and just being a person. Go out and talk to people and just introduce yourself. The one great thing that you can do in this industry is say, ‘Can I help?'” - Joel Thomas, Director of OEM Sales Data Center and Life Sciences at Siemens”If you asked me 7 years ago, I would say that Europe was way ahead when it came to automation technology. Now, I think the US has caught up, if not maybe surpassed it.” - Joel Thomas, Director of OEM Sales Data Center and Life Sciences at SiemensLinks & mentions:Siemens Intralogistics provides intelligent material handling tech that empowers intralogistics to meet demands and overcome challenges via AI-enhanced automation and sustainable design.MHI the nation's largest material handling, logistics and supply chain association - active since 1945.Halfway Crooks Beer is the Atlanta brewery where this episode was recorded, known for traditionally brewed lagers in the Summerhill neighborhood.Make sure to visit http://manufacturinghappyhour.com for detailed show notes and a full list of resources mentioned in this episode. Stay Innovative, Stay Thirsty.

Debi Evans shares her journey into alternative media and describes how the 2020 health crisis served as a data harvesting exercise and “warm-up act” for a broader globalist agenda. The discussion examines the UK's role as a laboratory for life sciences, where the population is subjected to experimental medical treatments and surveillance. These agendas (e.g. Absolute Zero, Agenda 2030) are designed to restrict human movement and enforce algorithmic tyranny. Furthermore, Debi explores the rise of transhumanism, warning that the integration of AI into daily life may lead to the eventual extinction of human autonomy. Ultimately, the conversation portrays a dystopian future where manufactured crises in health, energy, and water are used to usher in a new world order. Watch on BitChute / Brighteon / Rumble / Substack / YouTube *Support Geopolitics & Empire! Become a Member https://geopoliticsandempire.substack.com Donate https://geopoliticsandempire.com/donations Consult https://geopoliticsandempire.com/consultation **Listen Ad-Free for $4.99 a Month or $49.99 a Year! Apple Subscriptions https://podcasts.apple.com/us/podcast/geopolitics-empire/id1003465597 Supercast https://geopoliticsandempire.supercast.com ***Visit Our Affiliates & Sponsors! Above Phone https://abovephone.com/?above=geopolitics American Gold Exchange https://www.amergold.com/geopolitics Escape The Technocracy (15% off w/ GEOPOLITICS!) https://escapethetechnocracy.com/geopolitics Expat Money (FREE “WW3 Plan-B” Report!) https://expatmoney.com/geopolitics PassVult https://passvult.com Sociatates Civis https://societates-civis.com StartMail https://www.startmail.com/partner/?ref=ngu4nzr Wise Wolf Gold https://www.wolfpack.gold/?ref=geopolitics Websites X https://x.com/DebiEvansMatron Camp 3 News https://www.camp3news.com About Debi Evans Debi Evans is a retired NHS SRN and contributor to Camp 3 News among other independent media. *Podcast intro music used with permission is from the song “The Queens Jig” by the fantastic “Musicke & Mirth” from their album “Music for Two Lyra Viols”: http://musicke-mirth.de/en/recordings.html (available on iTunes or Amazon)